Laura M. Shelton, Ph.D. - Publications

Institution:
Boston College, Newton, MA, United States
Area:
metabolic therapy

22/46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Seyfried TN, Arismendi-Morillo G, Zuccoli G, Lee DC, Duraj T, Elsakka AM, Maroon JC, Mukherjee P, Ta L, Shelton L, D'Agostino D, Kiebish M, Chinopoulos C. Metabolic management of microenvironment acidity in glioblastoma. Frontiers in Oncology. 12: 968351. PMID 36059707 DOI: 10.3389/fonc.2022.968351  0.72
2019 Seyfried TN, Shelton L, Arismendi-Morillo G, Kalamian M, Elsakka A, Maroon J, Mukherjee P. Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma? Neurochemical Research. PMID 31025151 DOI: 10.1007/S11064-019-02795-4  0.644
2018 Flores RE, Brown AK, Taus L, Khoury J, Glover F, Kami K, Sarangarajan R, Walshe T, Narain NR, Kiebish MA, Shelton L, Chinopoulos C, Seyfried TN. Mycoplasma infection and hypoxia initiate succinate accumulation and release in the VM-M3 cancer cells. Biochimica Et Biophysica Acta. PMID 29580805 DOI: 10.1016/J.Bbabio.2018.03.012  0.681
2017 Kremer JC, Prudner BC, Lange SE, Bean GR, Schultze MB, Brashears CB, Radyk MD, Redlich N, Tzeng SC, Kami K, Shelton L, Li A, Morgan Z, Bomalaski JS, Tsukamoto T, et al. Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers. Cell Reports. 18: 991-1004. PMID 28122247 DOI: 10.1016/J.Celrep.2016.12.077  0.512
2016 Samanta D, Park Y, Andrabi SA, Shelton LM, Gilkes DM, Semenza GL. PHGDH Expression is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance and Lung Metastasis. Cancer Research. PMID 27280394 DOI: 10.1158/0008-5472.Can-16-0530  0.458
2016 Coloff JL, Murphy JP, Braun CR, Harris IS, Shelton LM, Kami K, Gygi SP, Selfors LM, Brugge JS. Differential Glutamate Metabolism in Proliferating and Quiescent Mammary Epithelial Cells. Cell Metabolism. PMID 27133130 DOI: 10.1016/J.Cmet.2016.03.016  0.381
2015 Tedeschi PM, Johnson-Farley N, Lin H, Shelton LM, Ooga T, Mackay G, Van Den Broek N, Bertino JR, Vazquez A. Quantification of folate metabolism using transient metabolic flux analysis. Cancer & Metabolism. 3: 6. PMID 26023330 DOI: 10.1186/S40170-015-0132-6  0.365
2015 Kim D, Fiske BP, Birsoy K, Freinkman E, Kami K, Possemato RL, Chudnovsky Y, Pacold ME, Chen WW, Cantor JR, Shelton LM, Gui DY, Kwon M, Ramkissoon SH, Ligon KL, et al. SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance. Nature. 520: 363-7. PMID 25855294 DOI: 10.1038/Nature14363  0.527
2014 Akgoc Z, Shelton LM, Ryan D, Zhu X, Seyfried TN. Abstract 4113: Restricted ketogenic diet reduces growth and distant organ metastasis in the murine VM-M3 metastatic tumor model Cancer Research. 74: 4113-4113. DOI: 10.1158/1538-7445.Am2014-4113  0.519
2013 Seyfried TN, Shelton LM, Huysentruyt LC. The VM mouse model of glioblastoma multiforme Neuromethods. 77: 39-55. DOI: 10.1007/7657_2012_34  0.707
2012 Seyfried TN, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P. Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer? Epilepsy Research. 100: 310-26. PMID 21885251 DOI: 10.1016/J.Eplepsyres.2011.06.017  0.786
2011 Seyfried TN, Kiebish MA, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P. Metabolic management of brain cancer. Biochimica Et Biophysica Acta. 1807: 577-94. PMID 20804725 DOI: 10.1016/J.Bbabio.2010.08.009  0.77
2010 Shelton LM, Huysentruyt LC, Mukherjee P, Seyfried TN. Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse. Asn Neuro. 2: e00038. PMID 20664705 DOI: 10.1042/An20100002  0.774
2010 Seyfried TN, Shelton LM, Mukherjee P. Does the existing standard of care increase glioblastoma energy metabolism? The Lancet. Oncology. 11: 811-3. PMID 20634134 DOI: 10.1016/S1470-2045(10)70166-2  0.534
2010 Shelton LM, Huysentruyt LC, Seyfried TN. Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model. International Journal of Cancer. Journal International Du Cancer. 127: 2478-85. PMID 20473919 DOI: 10.1002/Ijc.25431  0.79
2010 Seyfried TN, Shelton LM. Cancer as a metabolic disease. Nutrition & Metabolism. 7: 7. PMID 20181022 DOI: 10.1186/1743-7075-7-7  0.618
2010 Shelton LM, Mukherjee P, Huysentruyt LC, Urits I, Rosenberg JA, Seyfried TN. A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion. Journal of Neuro-Oncology. 99: 165-76. PMID 20069342 DOI: 10.1007/S11060-010-0115-Y  0.79
2010 Huysentruyt LC, Shelton LM, Seyfried TN. Influence of methotrexate and cisplatin on tumor progression and survival in the VM mouse model of systemic metastatic cancer. International Journal of Cancer. Journal International Du Cancer. 126: 65-72. PMID 19536778 DOI: 10.1002/Ijc.24649  0.787
2010 Shelton LM, Huysentruyt LC, Seyfried TN. Abstract 5421: Targeting glucose and glutamine for the metabolic management of systemic metastatic cancer Cancer Research. 70: 5421-5421. DOI: 10.1158/1538-7445.Am10-5421  0.774
2010 Shelton LM, Strelko CL, Roberts MF, Seyfried TN. Abstract 53: Krebs cycle substrate-level phosphorylation drives metastatic cancer cells Cancer Research. 70: 53-53. DOI: 10.1158/1538-7445.Am10-53  0.494
2008 Huysentruyt LC, Mukherjee P, Banerjee D, Shelton LM, Seyfried TN. Metastatic cancer cells with macrophage properties: evidence from a new murine tumor model. International Journal of Cancer. Journal International Du Cancer. 123: 73-84. PMID 18398829 DOI: 10.1002/Ijc.23492  0.795
2008 Mukherjee P, Faber AC, Shelton LM, Baek RC, Chiles TC, Seyfried TN. Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a. Journal of Lipid Research. 49: 929-38. PMID 18287616 DOI: 10.1194/Jlr.R800006-Jlr200  0.74
Low-probability matches (unlikely to be authored by this person)
2013 Smagghe BJ, Stewart AK, Carter MG, Shelton LM, Bernier KJ, Hartman EJ, Calhoun AK, Hatziioannou VM, Lillacci G, Kirk BA, DiNardo BA, Kosik KS, Bamdad C. MUC1* ligand, NM23-H1, is a novel growth factor that maintains human stem cells in a more naïve state. Plos One. 8: e58601. PMID 23505541 DOI: 10.1371/Journal.Pone.0058601  0.272
2020 Rai SK, Bril F, Hatch HM, Xu Y, Shelton L, Kalavalapalli S, Click A, Lee D, Beecher C, Kirby A, Kong K, Trevino J, Jha A, Jatav S, Kriti K, et al. Targeting Pheochromocytoma/Paraganglioma with polyamine inhibitors. Metabolism: Clinical and Experimental. 154297. PMID 32562798 DOI: 10.1016/J.Metabol.2020.154297  0.246
2013 Smagghe BJ, Stewart AK, Carter MG, Shelton LM, Bernier KJ, Hartman EJ, Calhoun AK, Hatziioannou VM, Lillacci G, Kirk BA, DiNardo BA, Kosik KS, Bamdad C. Human stem cells cultured in NM23-H1-MM over anti-MUC1* antibody surfaces express higher levels of naïve markers and lower levels of primed markers. Plos One. DOI: 10.1371/Journal.Pone.0058601.G006  0.243
2022 Samanta D, Park Y, Andrabi SA, Shelton LM, Gilkes DM, Semenza GL. Correction: PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis. Cancer Research. 82: 1153. PMID 35288733 DOI: 10.1158/0008-5472.CAN-21-4328  0.217
2019 Ghayee H, Shelton L, Rai S, Xu Y, Hatch H, Tevosian S, Hromas R. SUN-LB053 Metabolic Interaction of SAH and SAM in hPheo1 Cells Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Sun-Lb053  0.19
2023 Bala N, Yu L, Liu LP, Shelton L, Xu Y, Ghayee HK, Alli AA. Metabolic characterization and GAPDH dependent regulation of ENaC in hPheo1 wild-type and SDHB knockdown cells. Endocrinology. PMID 36763043 DOI: 10.1210/endocr/bqad026  0.176
2014 Copple IM, Shelton LM, Walsh J, Kratschmar DV, Lister A, Odermatt A, Goldring CE, Dinkova-Kostova AT, Honda T, Park BK. Chemical tuning enhances both potency toward nrf2 and in vitro therapeutic index of triterpenoids. Toxicological Sciences : An Official Journal of the Society of Toxicology. 140: 462-9. PMID 24798383 DOI: 10.1093/toxsci/kfu080  0.144
2015 Shelton LM, Lister A, Walsh J, Jenkins RE, Wong MH, Rowe C, Ricci E, Ressel L, Fang Y, Demougin P, Vukojevic V, O'Neill PM, Goldring CE, Kitteringham NR, Park BK, et al. Integrated transcriptomic and proteomic analyses uncover regulatory roles of Nrf2 in the kidney. Kidney International. PMID 26422507 DOI: 10.1038/Ki.2015.286  0.117
2012 Shelton L, Pendse G, Maleki N, Moulton EA, Lebel A, Becerra L, Borsook D. Mapping pain activation and connectivity of the human habenula. Journal of Neurophysiology. 107: 2633-48. PMID 22323632 DOI: 10.1152/Jn.00012.2012  0.106
2022 Nakazawa H, Wong LP, Shelton L, Sadreyev R, Kaneki M. Farnesysltransferase Inhibitor Prevents Burn Injury-Induced Metabolome Changes in Muscle. Metabolites. 12. PMID 36144205 DOI: 10.3390/metabo12090800  0.09
2010 Shelton LM. Fighting an uphill battle: Expansion barriers, intra-industry social stratification, and minority firm growth Entrepreneurship: Theory and Practice. 34: 379-398. DOI: 10.1111/j.1540-6520.2010.00379.x  0.057
2008 Shelton LM, Danes SM, Eisenman M. Role demands, difficulty in managing work-family conflict, and minority entrepreneurs Journal of Developmental Entrepreneurship. 13: 315-342. DOI: 10.1142/S1084946708000983  0.056
2012 Shelton L, Becerra L, Borsook D. Unmasking the mysteries of the habenula in pain and analgesia Progress in Neurobiology. 96: 208-219. PMID 22270045 DOI: 10.1016/J.Pneurobio.2012.01.004  0.055
2013 Wilkin CL, Rubino C, Zell D, Shelton LM. Where technologies collide: A technology integration model Cutting-Edge Technologies in Higher Education. 6: 81-106. DOI: 10.1108/S2044-9968(2013)000006E006  0.037
2000 Shelton LM. Merger market dynamics: Insights into the behavior of target and bidder firms Journal of Economic Behavior and Organization. 41: 363-383.  0.023
2009 SHELTON L. Kathryn A. Sloan, Runaway Daughters: Seduction, Elopement, and Honor in Nineteenth-Century Mexico (Albuquerque: University of New Mexico Press, 2008), pp. xi+244, $27.95, pb. Journal of Latin American Studies. 41: 622-623. DOI: 10.1017/S0022216X09990447  0.018
2017 Shelton L. Bodies of Evidence:Honor, Prueba Plena,and Emerging Medical Discourses in Northern Mexico's Infanticide Trials in the Late Nineteenth and Early Twentieth Centuries The Americas. 74: 457-480. DOI: 10.1017/tam.2017.14  0.015
2010 Shelton LM. For tranquility and order For Tranquility and Order. 1-206.  0.014
2013 Shelton LM, Park BK, Copple IM. Role of Nrf2 in protection against acute kidney injury. Kidney International. 84: 1090-5. PMID 23783243 DOI: 10.1038/ki.2013.248  0.012
2018 Shelton L. Love, Gender, and Family in Late Colonial and Early Republican Latin America Journal of Women's History. 30: 170-176. DOI: 10.1353/jowh.2018.0009  0.01
2015 Nikina A, Shelton LM, Leloarne S. An examination of how husbands, as key stakeholders, impact the success of women entrepreneurs Journal of Small Business and Enterprise Development. 22: 38-62. DOI: 10.1108/JSBED-01-2012-0002  0.01
2006 Shelton LM. Female entrepreneurs, work-family conflict, and venture performance: New insights into the work-family interface Journal of Small Business Management. 44: 285-297. DOI: 10.1111/j.1540-627X.2006.00168.x  0.01
1999 Shelton L, Radding C. Wandering Peoples: Colonialism, Ethnic Spaces, and Ecological Frontiers in Northwest Mexico, 1700-1850. International Migration Review. 33: 213. DOI: 10.2307/2547340  0.01
1999 Shelton L. Book Review: Wandering Peoples: Colonialism, Ethnic Spaces, and Ecological Frontiers in Northwest Mexico, 1700–1850 International Migration Review. 33: 213-214. DOI: 10.1177/019791839903300121  0.01
Hide low-probability matches.